Danaher
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Danaher often yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes Danaher occasionally embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues at times. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of Danaher
Rainer M. Blair
Summary:
Headquartered in Washington, D.C., Washington D.C., Danaher is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Rainer M. Blair and Mitchell P. Rales, Steven M. Rales serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $4,600 to Republican causes and $84,550 to Democratic causes. Under their tenure, Danaher currently holds a 'Medium Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$4,600
$84,550
Republican
Democrat
Shareholder Proposals
Expand Summary
Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
---|---|---|---|---|---|
5/7/24 | Governance | John Chevedden | Special Shareholder Meeting Improvement | Against | 43.11% |
5/7/24 | Social | As You Sow | Report on Company's Diversity, Equity, and Inclusion Efforts | Against | 13.96% |
5/9/23 | Governance | John Chevedden | Require Two Seperate People Hold the Offices of Chairman and CEO | Against | 38.30% |
5/9/23 | Environmental | As You Sow | Greater Disclosure of Material Corporate Diversity | Against | 16.10% |
5/10/22 | Governance | N/A - Undisclosed | Special Meetings - Reduce Ownership Req. to 10% | Against | 43.13% |